Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: A study based on CGM in type 2 diabetes in China
Aim: To evaluate the efficacy and safety of URLi (ultra rapid lispro insulin) compared to insulin lispro as bolus insulin with basal insulin using CGM in the individuals with type 2 diabetes(T2D) in China.Methods:This was a double-blind, randomized, parallel, prospective, phase 3 study.Subjects with uncontrolled T2D